B

DaVita Inc. DVA

$191.35 -$3.47-1.78% NYSE
Recommendation
Dividend Power Score
Day's Range
$188.75$191.90
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

DVA Rating

Reward
Risk

DVA Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

DVA Company Overview

DaVita Inc. is a U.S.-based healthcare company focused primarily on kidney care services, with operations centered on dialysis treatment for patients with chronic kidney disease and end-stage kidney disease (ESKD). The company operates within the healthcare services and renal care industries and is one of the largest dialysis providers in the United States. DaVita generates most of its revenue through outpatient dialysis treatments reimbursed by government healthcare programs, commercial insurers, and managed care organizations. In addition to dialysis care, the company provides laboratory services, vascular access management, care coordination, and integrated kidney care programs designed to improve clinical outcomes and reduce total healthcare costs.

The company traces its origins to Total Renal Care Holdings, which expanded significantly during the 1990s through acquisitions before adopting the DaVita name in 2000. Over time, DaVita evolved from a traditional dialysis clinic operator into a broader kidney care platform emphasizing value-based care arrangements and integrated patient management. Its strategic positioning is supported by a large national clinic network, longstanding payer relationships, extensive clinical infrastructure, and experience managing patients with complex chronic conditions. Public filings and major financial reporting consistently identify the company’s scale, recurring treatment demand, and integrated care capabilities as core competitive strengths.

Data compiled by narrative technology. May contain errors.
Sector

DVA Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

DVA Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

DVA Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

DVA Price History

Loading...
52-Week Range62% of range
Current
$191.35
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

DVA Valuation

Market Cap
Market Cap Rank
#2,155
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

DVA Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

DVA Corporate Info

Phone Number
720 631 2100
Address
2000 16th Street
Denver, CO 80202
Country
Year Founded

DVA Filings

Filing Date
Thursday, October 29, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 8 and 12 (est)

DVA Headlines

11/4/2026 - Zacks Investment Research